financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Shares Of C.h. Robinson Worldwide, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Shares Of C.h. Robinson Worldwide, Inc.
May 2, 2024 12:52 PM

03:40 PM EDT, 05/02/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target price of $87, raised $11, reflects a 21x multiple of projected '25 EPS, slightly above CHRW's historical forward average. We lift our '24 EPS estimate by $0.36 to $3.55 and '25's by $0.12 to $4.12. Q1 EPS of $0.86 vs. $0.98, beat the consensus view by $0.23. CHRW said it gained market share in Q1 in its Truckload business, and even though Truckload volumes fell 0.5% Y/Y (better than the broader index), CHRW was able to also eke out improved gross profit per truckload, which we think is a strong achievement. The geopolitical strife in the Middle East also led to some new wins for CHRW in its global forwarding business. Shares are up 14% today, which we think reflects some optimism over the sudden turnaround in gross profit metrics in March (+7% in March vs. -3% in February), but with shares now trading above historical forward average, we think a positive inflection point in the business is now priced in.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Shares Of Johnson & Johnson To Buy From Hold
Research Alert: CFRA Raises Opinion On Shares Of Johnson & Johnson To Buy From Hold
Oct 14, 2025
11:05 AM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Q3 earnings and the announcement of the separation of Orthopedics, we raise our target to $220 from $166. This is based on 19.2x our 2026 EPS estimate and is...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Blackrock, Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Blackrock, Inc.
Oct 14, 2025
12:30 AM EDT, 10/15/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $95, to $1,340, valuing BLK shares at 22x our newly initiated 2027 adjusted EPS estimate of $60.50, and at 25x our 2026 EPS...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Jpmorgan Chase & Co.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Jpmorgan Chase & Co.
Oct 14, 2025
12:20 PM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $340, applying a forward P/E of 15.5x, near the three-year historical average at 15.0x on normalized earnings. We keep our EPS estimates at...
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of The Goldman Sachs Group
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of The Goldman Sachs Group
Oct 14, 2025
02:40 PM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $850, applying a forward P/E of 15.6x our 2026 earnings estimate compared to the five-year historical average for normalized EPS at 15.5x. We...
Copyright 2023-2026 - www.financetom.com All Rights Reserved